TECH & INNOVATIONAs the world slowly eases back on traveling in the shadow of other COVID-19 variants, Lufthansa is taking one step ahead in safety by approving a new pre-flight rapid home test kit for its passengers.
Sleep talking is a type of parasomnia disorder that even experts do not exactly know why it happens. But there are some tips that could help people prevent talking while they sleep.
A recent study on coffee consumption finds that excessive drinking of the world's famous beverage can increase the risk of dementia, stroke, and could even shiirnk brain volume.
Other people suffer from the highly contagious disease for longer, battling its effects for weeks or months after. These are the COVID-19 "Long Haulers": and their stories see the light of day thanks to a new book.
As the world is slowly easing back to life post-COVID-19, a new strain is forcing countries to put up their defenses: the more infectious Delta Variant.
Researchers from Swansea University have developed bioink using human cells and plant-based materials to 3D print facila features such as nose and ears for facial reconstructive surgery.
The National Weather Services earlier today said people may suffer respiratory problems due to a persistent bloom of poisonous red tide off the Gulf Coast of Florida.
Scientists have been using AlphaFold artificial intelligence (AI) system to accelerate scientific projects that aim to develop new drugs for diseases and enzymes that can break down plastics. It offers a large dataset that unlocks advances in medicine.
While the delta variant of COVID-19 has rapidly become the prevalent strain in the United States, another strain, the lambda variant is also making the headline after it was recently identified in Peru.
Breakthrough infections are rare but not impossible even after getting vaccinated. So what should fully vaccinated people do when they were exposed to infected COVID-19 patients?
A Chinese government health official recently denied that the Wuhan Institute of Virology or WIV workers were not infected with COVID-19 shortly before the virus first occurred.
A recent study published in The New England Journal of Medicine confirms that the Pfizer vaccine works effectively against the COVID-19 delta variant, with a whopping 88% efficacy.